Register
Register
Register

Project cooperationUpdated on 16 January 2026

Partner Search: 3D Organoid Expertise for High-Fidelity GBM Device Validation

Strategy & Research Associate at Migration Biotherapeutics

Cambridge, United Kingdom

About

Migration Biotherapeutics is developing the ALIGHT device, an innovative "ecological trap" designed to manage refractory glioblastoma by exploiting natural cell migratory instincts via aligned electrospun nanofibers.

Under the HORIZON-MISS-2026-02-CANCER-03 call, we are seeking research organisations specialising in high-fidelity 3D cancer organoid models and the replication of the tumour microenvironment. We seek to enhance the in vitro validation of our non-pharmacological device by testing its performance in complex 3D models that accurately mimic the human brain. This partnership is vital to establishing definitive proof-of-concept evidence. Migration Bio offers a unique industrial-academic bridge.

Stage

  • Design - setting the project scope
  • Completing the consortia

Topic

  • HORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers

Type

  • Consortium/Coordinator seeks Partners
  • Offering Expertise to Consortias

Organisation

Migration Biotherapeutics

Start-up

Cardiff, United Kingdom

Similar opportunities

  • Project cooperation

    Seeking In Silico Modelling for Nanofiber-Based Cancer "Ecological Traps"

    • Completing the consortia
    • Offering Expertise to Consortias
    • Design - setting the project scope
    • Consortium/Coordinator seeks Partners
    • HORIZON-MISS-2026-02-CANCER-01: Virtual Human Twin (VHT) Models for Cancer Research

    Enoch Alex

    Strategy & Research Associate at Migration Biotherapeutics

    Cambridge, United Kingdom

  • Project cooperation

    Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers

    • Offering Expertise to Consortias
    • HORIZON-MISS-2026-02-CANCER-07: Improve the Quality of Life of older cancer patients
    • HORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers

    Javier Carmona

    Head of Scientific Strategy at Vall d'Hebron Institute of Oncology

    BARCELONA, Spain

  • Project cooperation

    Extracellular vesicles analysis for cancer diagnostics and pathology

    • Offering Expertise to Consortias
    • Ideation - identifying the project idea
    • HORIZON-MISS-2026-02-CANCER-01: Virtual Human Twin (VHT) Models for Cancer Research
    • HORIZON-MISS-2026-02-CANCER-06: Development of a research capacity building programme on cancer with and for Ukraine
    • HORIZON-MISS-2026-02-CANCER-03: Pragmatic clinical trials to optimise immunotherapeutic interventions for patients with refractory cancers

    Masoud Darabi Amin

    Group leader at University Hospital Schleswig-Holstein (UKSH)

    Lübeck, Germany